Related Experiment Video
Updated: May 20, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
[Pediatric inflammatory bowel disease: is it still increasing?]
Ana Fernandes1, Sílvia Bacalhau, José Cabral
1Unidade de Gastrenterologia e Hepatologia Infantil, Hospital de Dona Estefânia, CHLC, Lisboa, Portugal.
Inflammatory Bowel Disease (IBD) incidence in children is rising, with Crohn's disease (CD) being most common. Diagnosis times are improving, though presentation age remains consistent.
Area of Science:
- Pediatric Gastroenterology
- Chronic Disease Epidemiology
- Inflammatory Bowel Disease (IBD) Research
Context:
- Inflammatory Bowel Disease (IBD), encompassing Crohn's disease (CD), Ulcerative Colitis (UC), and Indeterminate Colitis (IC), is increasingly diagnosed in pediatric populations.
- Global incidence of IBD has shown a significant upward trend over the past five decades, particularly in industrialized nations.
Purpose:
- To characterize the pediatric IBD population diagnosed and followed at Hospital de Dona Estefânia (HDE).
- To analyze trends in IBD diagnosis, clinical presentation, and time to diagnosis in children over a 23-year period (1987-2009).
Summary:
- A retrospective study of 100 pediatric IBD patients revealed a rising incidence, with CD being the most prevalent diagnosis (59%).
- The period 2005-2009 saw the highest number of new cases, averaging 11 per year, compared to 1.5 per year between 1987-1992.
- While the time from symptom onset to diagnosis decreased significantly (from 9 to 4 months), the mean age at diagnosis (10.5 years) and common presenting symptoms (abdominal pain, diarrhea, hematochezia) remained consistent.
Impact:
- Highlights the increasing burden of pediatric IBD, emphasizing the need for early detection and management strategies.
- Provides valuable epidemiological data on pediatric IBD trends, informing public health initiatives and clinical practice guidelines.
- Demonstrates improvements in diagnostic timeliness, potentially leading to better patient outcomes in pediatric IBD.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...

